Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03760185 · ClinicalTrials.gov registry record · Phase 2
Pupil Dilation for Treatment of IFIS
A Phase 2 study, sponsored by Denver Health and Hospital Authority.
- Completed
- Registry status
- Phase 2
- Development phase
- 13
- Enrollment target
NCT03760185: Completed Phase 2 study, sponsored by Denver Health and Hospital Authority.
NCT03760185 is a Phase 2 study that has completed, run by Denver Health and Hospital Authority. The registered enrollment target is 13 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03760185, a Phase 2 study, has completed, sponsored by Denver Health and Hospital Authority.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 13 participants
- Enrollment target
Study Summary
A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.
Primary Outcome
The primary outcome measure is pupil diameter size post dilation (using standard dilating medications of phenylephrine 10%, tropicamide 1%, and cyclopentolate 1%) of the brimonidine tartrate pre-treated eye compared to the non-treated eye
Interventions
- DRUG Brimonidine Tartrate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2019-01-04 |
| Est. Completion | 2020-09-25 |
| Phase | Phase 2 |
What the finished NCT03760185 record still lists
NCT03760185 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 13 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 1 intervention - of which Brimonidine Tartrate is the first listed.
NCT03760185 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03760185 about?
NCT03760185 is a clinical study titled "Pupil Dilation for Treatment of IFIS". A novel intervention for targeting the treatment of Intraoperative Floppy Iris Syndrome.
What is the current status of trial NCT03760185?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 13 participants. The study started on 2019-01-04. Estimated completion is 2020-09-25.
What interventions are being tested in trial NCT03760185?
The interventions under investigation include: Brimonidine Tartrate (DRUG).
Who is sponsoring clinical trial NCT03760185?
This trial is sponsored by Denver Health and Hospital Authority, which has 73 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03760185's enrollment target sits among peer trials
13 1947th of 2000 higher than 53 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03125655 · 13 participants
Regulation of Inflammatory Genes in Psoriasis
- NCT03774446 · 13 participants · Phase 2
Multicenter Study of Seliciclib (R-roscovitine) for Cushing Disease
- NCT03830151 · 13 participants · Phase 1
Hyperpolarized Carbon C 13 Pyruvate in Diagnosing Glioma in Patients With Brain Tumors
- NCT04573231 · 13 participants · Phase 2
Evaluation of PSMA in HER2- AR+ Metastatic Breast Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI